The World Health Organization (WHO) has granted prequalification to the molecular diagnostic test for tuberculosis (TB) called Xpert® MTB/RIF Ultra.
FDA rejects Checkpoint Therapeutics’ PD-L1 drug cosibelimab over manufacturing issues
Checkpoint Therapeutics’ anti-PD-L1 antibody has been turned down by the FDA due to manufacturing issues, sending its share price down 45% premarket on Monday. The